期刊文献+

脊髓转移瘤中一氧化氮、血管内皮生长因子的表达

The Pathological Significance of NO and VEGF in Spinal Metastasis Tumor
原文传递
导出
摘要 目的 讨论一氧化氮(NO)和血管内皮生长因子(VEGF)在脊髓转移瘤中的表达。方法 采用免疫组化法检测17例脊髓种植性转移瘤活检标本中的诱导型NO合酶(iNOS)、VEGF和Ⅷ因子相关抗原(FⅧRAg)的表达,分析其病理学意义。结果 ①转移瘤组iNOS阳性表达率为58.8%,而对照组iNOS无表达(P<0.001);②转移瘤iNOS阴性组微血管密度值为(20.80±11.74)个/视野,iNOS阳性组为(39.20±18.55)个/视野,两者差异有显著性(P<0.05);③转移瘤组VEGF阳性表达率为70.6%,明显高于对照组的20%(P<0.05);④VEGF阳性组微管密度为(41.03±20.19)个/视野,阴性组为(20.03±11.60)个/视野,二者间差异有显著性(P<0.01);⑤iNOS阳性组中VEGF阳性细胞数明显高于iNOS阴性组(P<0.01)。结论 NO和VEGF在脊髓转移瘤的形成中发挥重要作用。 Objective To discuss the pathological significance of nitric Oxide (NO) and Vascular endothelial growth factor(VEGF) in spinal metastasis tumor. Methods Immunohistochemical method was used to detect the expressions of inducible nitric oxide synthase (iNOS), VEGF and factor Ⅷ related antigen (FⅧRAg) in 17 cases of spinal metnstasis tumor bioshop tissues. Results ①58.8% posifve rate of iNOS in metastasis tumor, while no expression in control, showed great difference(P<0.001).②The microvascular density(MVD) was(20.80±11.74)per-field in iNOS negative while(39.20±18.55)per-field in iNOS positive with great difference(P<0.05).③The positive of VEGF in metastasis tumor(70.6%)was much higher than that in control(20%).④The MVD of VEGF was(41.03±20.19)per-field in positive and(20.03±11.60)per-field in negative(P<0.01);⑤The VEGF positive cells in iNOS positive Samples was more than that in iNOS negative ones(P<0.01). Conclusion NO and VEGF play the important roles in the formation of spinal metastasis tumor.
出处 《中国自然医学杂志》 CAS 2003年第4期201-202,共2页 Chinese Journal of Natural Medicine
关键词 脊髓转移瘤 一氧化氮 血管内皮生长因子 免疫组织化学 Nitic oxide Endothelium vascular Growth substances Neoplasm metastasis
  • 相关文献

参考文献10

  • 1[1]Folkman J.Tumor angiogenesis: therapeuic implications. N Engl J Med, 1971, 285: 1182- 1186.
  • 2[2]Hanahan D, Folkman J.Patterns and emerging mechanisms of the angionenic seitch during tumorigenesis. Cell, 1996, 86:353 - 364.
  • 3[3]Chen JJ, Peek K, Hong TM, er al. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res,2001, 61: 5223- 5230.
  • 4[4]Gallo O, Maqsini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst, 1998, 90: 587- 596.
  • 5[5]Shi Q, Huang SY, Jiang WD, et al. Direct correlation between nitric oxide synthase Ⅱ inducibility and metastatic ability of UV - 2237 murine fibrosarcoma cells carrying mutant p53.Cancer Res, 1999, 59: 2072-2075.
  • 6[6]Ambs S, Bennett WP, Merriam WG, etal. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.Br J Cancer, 1998, 78:233 - 239.
  • 7[7]Toi M, Kondo S, Suzuki H, et al. Quantitatice analuses of Vascular endothelial growth factor in primary breast cancer. Cancer Res, 1996, 77:1101 - 1105.
  • 8[8]Farelli M, Locopo N, Gattuso D, et al. Assessment of tumor Cascularization: immunohistochemical and non- invasice methods.Int J Biol Markers, 1999, 14:218 - 231.
  • 9[9]Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factorinduced but not basic fibroblast growth factor- induced angiogenesis. J Clin Incest, 1997, 99:2625 - 2634.
  • 10[10]Metsuyama K, Chiba Y, Sasaki M, et al. Tumor angiogenesis as a prognostic marker in operable non - small cell lung cancer. Ann Thorac Surg, 1998, 65:1405-1409.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部